BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 18, 2008
View Archived Issues
Studies show analgesic efficacy of ARRY-797 in postsurgical dental pain
Read More
Pooled GOUT 1 and GOUT 2 data detail effects of pegloticase
Read More
Recent University of Aberdeen patent discloses novel agents for bone disorders
Read More
New therapeutic agents for neurological disorders reported in recent patent literature
Read More
Thalidomide not effective in treating amyotrophic lateral sclerosis
Read More
Antimicrobial activity of host defense peptide mimetics described
Read More
NIH awards SBIR grant to BioSante to develop pulmonary delivery of IFN-alpha
Read More
Boehringer Ingelheim commences phase III pivitol program for Vargatef
Read More
DSMC authorizes Bioniche to continue phase III Urocadin trial in bladder cancer
Read More
Innocoll receives FDA fast track designation for Gentamicin Surgical Implant
Read More
Relistor approved in Australia for opioid-induced constipation
Read More
Life Science Pharmaceuticals enters into agreement with Abbott for Antibody 806
Read More
Eli Lilly and United Therapeutics enter license and supply agreement for PAH
Read More
SciClone reaches agreement with FDA on SPA for phase III thymalfasin trial
Read More
Solvay discontinues R&D activities of antiobesity compound SLV-319
Read More
Theratechnologies completes treatment of patients in extension phase of tesamorelin trial
Read More
Biotie acquires Elbion NV's subsidiary Elbion GmbH
Read More
Proteome Systems changes name to Tyrian Diagnostics
Read More
Affymax completes enrollment in EMERALD 2 phase III clinical trial of Hematide
Read More
Serenity initiates phase II clinical study of intranasal drug for urology indication
Read More
Novel dopamine D3 receptor agonists and antagonists described by Pfizer
Read More
Preclinical activity of PF-03800130 shows benefit in bipolar disorder-associated mood symptoms
Read More
Phase II results with rivaroxaban in acute coronary syndromes reported
Read More
New compounds for hypogonadism described in recent GSK patent
Read More